Home / Inspections / 1206056

FDA Inspection 1206056 — Chartwell Pharmaceuticals Congers, LLC

Chartwell Pharmaceuticals Congers, LLC — FEI 3008897678

The FDA completed an inspection of Chartwell Pharmaceuticals Congers, LLC on May 24, 2023 in Congers, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 24, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Congers, NY (United States)

Facility

Other inspections at this facility

  • 1277530 (OAI Tue Nov 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1230475 (VAI Mon Apr 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1068395 (VAI Wed Sep 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 992472 (VAI Tue Nov 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 885844 (NAI Mon Jun 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources